- Shares up over 47% in premarket trading
- vTv will receive upfront payment and is eligible for future milestones and royalties
- Partner intends to develop COPD treatment... read more
CAMP4 Therapeutics is on a mission to modernize the way the pharma industry discovers new treatments. Operating at the intersection of biology and computation, CAMP4 is building on seminal... read more
T2 Biosystems, Inc. (Nasdaq:TTOO) announced on 5/30/18 that it is commencing an underwritten registered public offering of 5,650,000 shares of its common stock. T2 Biosystems also intends to grant... read more
Neural Analytics, Inc. announced on 5/30/18 that it received FDA 510(k) clearance for its NeuralBot System, a robotic assistance technology which automatically adjusts orientation and position of... read more
Researchers from The Sport Science Center at Texas Christian University, Texas Health Sports Medicine, and the University of Wisconsin–La Crosse evaluated the usefulness of biomarker testing in... read more